There, the stable gastric pentadecapeptide BPC 157 studies, already largely reviewed [1,2,3,4,5,6,7,8,9,10,11], share some major worth-mentioning points given its development in the early 1990s [15] as a late outbreak of the already advanced, but not fully implemented, cytoprotection concept
Extracellular matrix components in the pathogenesis of type 1 diabetes
Absolwent (magisterium) Szkoy Gwnej Handlowej - wrd TOP 5 rocznika 1995 i Uniwersytetu Mikoaja Kopernika w Toruniu (studia podyplomowe z zakresu prawa handlowego)
published data in Endocrinology showing the peptide's ability to reduce adipose tissue in ob/ob mice by 50% over 19 days without affecting lean mass or circulating IGF-1 [1]
Great product@ Weight didnt change
[6] More specifically, the study also hypothesized that BPC-157 might accelerate the outgrowth of tendon fibroblasts from tendon explants